SCHEMBL6434643

SCHEMBL6434643

CCCCCCCCCCCCCCCCC(C)C(=O)OCC(O)CO

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.61
▸ DUSP3 P51452 1/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ DGKA P23743 1/20 0.52
▸ USP2 O75604 1/20 0.50
▸ FAAH O00519 4/20 0.47
▸ FFAR4 Q5NUL3 1/20 0.46
▸ FFAR1 O14842 1/20 0.46
▸ CA1 P00915 2/20 0.46
▸ GPR84 Q9NQS5 5/20 0.44
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675241 1.00 KDM4E (0.61) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL16675242 1.00 KDM4E (0.61) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL18036545 1.00 KDM4E (0.61) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL30019360 0.93 KDM4E (0.56) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL26273160 0.91 CA1 (0.50) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL30632279 0.91 DGKA (0.67) KDM4EDUSP3MEN1KMT2ALMNA
Hexadecane SCHEMBL28029400 0.88 KDM4E (0.67) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL252664 0.85 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL14778640 0.85 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL127957 0.85 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578214-A1 FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL AND USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF OBESITY LTP Lipid Technologies Provider AB (SE) 2005-09-28 — — EP claimed
WO-2004057982-A1 FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL AND USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF OBESITY LTP LIPID TECHNOLOGIES PROVIDER AB (SE) 2004-07-15 — — WO claimed
EP-1578214-A1 FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL AND USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF OBESITY LTP Lipid Technologies Provider AB (SE) 2005-09-28 — — EP disclosed
WO-2004057982-A1 FOOD COMPOSITION COMPRISING A SATIETY ENHANCING AMOUNT OF TRIACYLGLYCEROL AND USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OR PREVENTION OF OBESITY LTP LIPID TECHNOLOGIES PROVIDER AB (SE) 2004-07-15 — — WO disclosed
Send feedback